Skip to main content
OpenTrials
Completed

NCT Number: NCT01911689

Magnetic Resonance Imaging Study of Acute Pancreatitis

To quantitatively analyze the T2* values of the head, body, and tail of normal pancreas, and observe the value of GRE T2*-weighted MRI in the diagnosis of acute pancreatitis and the relationship between the T2* value and the severity of AP.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Affiliated Hospital of North Sichuan Medical College

Nanchong, Sichuan, 637000, China

About this study

  • We design a prospective study about "Magetic Resonance Imaging Study of Acute Pancreatitis".
  • We apply for an account and register our study on the clinicalTrials.
  • In patients with acute pancreatitis, imaging is recommended to confirm the clinical diagnosis, investigate the etiology, and grade the severity of the disease . MR had the excellent resolution of soft tissue,and it has earned an ever more important role in the diagnosis of AP. With the continuous development of MR scanning techniques, the sequence of a multi-echo gradient recalled echo (GRE) T2*-weighted imaging (T2*WI), which acquires a spin echo signal, T2* relaxation acquires a gradient echo signal, is a relatively new MRI technique. The sequence of a GRE T2*WI requires high uniformity of the magnetic field, plus it can provide the T2* value, which can indirectly reflect changes in tissue biochemical components, thus it can be used for the early diagnosis quantitative diagnosis of some diseases .
  • This calculation process for T2* value is completed using post-processing software on the workstation(Advantage workstation 4.4; GE Halthcare) directly after scanning.
  • AP is a process of inflammation diffusion, in which cell edema will lead to hydrogen proton increase. In the inflammatory exudation process, T2* value will change. So we conduct our research. In this study, we will observe pancreas in the normal pancreas and AP, and discuss the relationship between T2* value and that of AP graded by the MR severity index (MRSI) and Acute Physiology And Chronic Healthy Evaluation II (APACHE II) scores.
  • However, until now, there is no research on the sequence applied in the patients with AP.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • acute onset of abdominal pain;
  • pancreatitis at first onset;
  • three-fold elevated amylase or lipase, excluding other causes of elevated enzymes; and
  • abdominal MR examination.

Exclusion criteria

  • inability to cooperate when MR imaging was performed;
  • a history of chronic pancreatitis;
  • AP due to pancreatic carcinoma;
  • hypoproteinemia;
  • with hypoproteinemia and other peritoneal/ retroperitoneal infection diseases ;
  • with iron deposition disorder (e.g. diabetes or blood system diseases).

Treatment and study plan

Primary outcomes

  1. The T2* Values in the Diagnosis of AP

    Time frame: 1 year

    Compare the difference of the T2* value between the AP group and the control group.

Secondary outcomes

  1. The Difference of T2* Value Between the Edematous AP and Necrotizing AP

    Time frame: 1 year

    Compare the difference of the T2* value between the edematous AP group and necrotizing AP group

  2. The T2* Value in Different Severity of AP According to MRSI

    Time frame: 1 year

    AP was graded as mild (0-3 points), moderate (4-6 points) or severe (7-10 points), according to the MR-severity index (MRSI) which was derived from the CT-severity index .

  3. The Relationship Between the T2* Value and the Severity of AP According to Apache II

    Time frame: 1 year

    In clinical practice, the physician usually used the APACHE II to evaluate the severity of acute pancreatitis. AP was graded as mild (0-7 points) and severe AP (≥8 points) according to the APACHE II scoring system.

Sponsors and collaborators

Lead sponsor

Affiliated Hospital of North Sichuan Medical College

Other

Registry information

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Jul 30, 2013
Registry last updated
Aug 24, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.